US Vice President Kamala Harris Advocates Marijuana Reform, Calling Restrictions "Absurd"

Regulations by 2FIRSTS.ai
Mar.18.2024
US Vice President Kamala Harris Advocates Marijuana Reform, Calling Restrictions "Absurd"
US Vice President Kamala Harris criticized federal marijuana restrictions, calling them "absurd" at an event with advocates and pardon recipients.

According to the US media Proceso, Vice President Kamala Harris stated on March 15th that "no one should be incarcerated for smoking marijuana," while also criticizing the current federal restrictions on marijuana as "absurd."

 

Prominent figures attending the event not only include Kamala Harris, but also rapper Fat Joe, who has long advocated for the legalization of marijuana, and those who have been pardoned by President Joe Biden for offenses related to possession of marijuana.

 

Harris broke his silence and firmly spoke out.

 

Treating marijuana as being equally dangerous as heroin, and even more dangerous than fentanyl, is absurd and, not to mention, blatantly unjust.

 

Currently, there is a growing expectation that the Drug Enforcement Administration (DEA) in the United States will modify the current classification of marijuana, considering it to be as addictive as LSD or heroin. In 2023, the Department of Health in the United States even recommended removing marijuana from the "Schedule I" category, which is reserved for substances deemed to have no medical use, and moving it to the lower-risk "Schedule III" category. While the final decision rests with the DEA, the specific timeline for this change is still uncertain.

 

The high risk classification of marijuana in the "schedule one" category has resulted in harsher penalties for those who use or sell marijuana, leading to a disproportionate incarceration rate among Hispanic and African American populations in the United States.

 

In the face of the upcoming reelection in November, Joe Biden is making efforts to attract the votes of young people, most of whom support the legalization of marijuana.

 

Despite this, the current marijuana policies in the United States vary widely. 24 states and the District of Columbia (Washington D.C.) have legalized marijuana for recreational use, and 38 out of 50 states allow for marijuana use for medical purposes. However, in some states and at the federal level, marijuana remains classified as an illegal substance.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.
Nov.10
Product | Semi-Embedded Display + “Smart Memory System”: OXBAR Launches New Magnetic Vape MAGLINK
Product | Semi-Embedded Display + “Smart Memory System”: OXBAR Launches New Magnetic Vape MAGLINK
OXBAR has launched the MAGLINK vape on its official website, featuring a magnetic structure and a smart memory function. The website lists the device as offering 50,000 puffs, a 1500 mAh battery, and four adjustable power levels. The product has already appeared across multiple Canadian sales channels, where the stated puff count, e-liquid capacity, and other specifications differ notably from those shown on the official site.
Dec.12 by 2FIRSTS.ai
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.
Dec.08 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Market research firm LP Information has released a global e-cigarette market report forecasting that the e-cigarette device market—including both disposable and reusable devices—will reach US$34.29 billion by 2031, with a 9.4% CAGR from 2025 to 2031.
Oct.16
Russia's Perm Legislators Approve Full Ban on Vape Products in Regional Retail Market
Russia's Perm Legislators Approve Full Ban on Vape Products in Regional Retail Market
2Firsts, November 28, 2025 — The Legislative Assembly of Perm Krai has passed a law banning the retail sale of vape products and other nicotine-aerosol devices, effective March 1, 2026. Individuals found selling such items will face fines between ₽15,000–₽20,000 (about US $180–240), while companies face ₽50,000–₽100,000 (about US $600–1,200). The ban covers all electronic nicotine delivery systems (ENDS), heated-tobacco devices, and their components, regardless of nicotine content.
Nov.28 by 2FIRSTS.ai